Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
about
Mesalamine in the treatment and maintenance of remission of ulcerative colitisInfliximab is superior to other biological agents for treatment of active ulcerative colitis: A meta-analysisPharmacokinetics in Wistar Rats of 5-[(4-Carboxybutanoyl)Amino]-2-Hydroxybenzoic Acid: A Novel Synthetic Derivative of 5-Aminosalicylic Acid (5-ASA) with Possible Anti-Inflammatory ActivityRed-Brown Urine Discolouration in Two Patients Taking Mesalamine.Safety of 5-Aminosalicylic Acid Derivatives in Patients with Sensitivity to Acetylsalicylic Acid and Nonsteroidal Anti-inflammatory Drugs.Management of inflammatory bowel disease: past, present and future.Pediatric ulcerative colitis: a practical guide to management.The safety of non-biological treatments in Ulcerative Colitis.Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.Design, Synthesis, and Testing of a Molecular Truck for Colonic Delivery of 5-Aminosalicylic Acid.Producing xylan/Eudragit® S100-based microparticles by chemical and physico-mechanical approaches as carriers for 5-aminosalicylic acidInaccuracies concerning Salofalk granules
P2860
Q26865546-D8DDD9BA-DA7E-499A-9C25-E61511C79F5EQ27006683-002145BD-D19C-4946-A365-EE6F5F3D9954Q36084796-B8EB5C5B-B00D-449D-BA60-5C3DDC03A836Q37219195-8AC3D507-9EBE-47DB-AB11-DBF62C318619Q37635428-7D8D1475-516F-4847-A818-B027AA9B36C5Q38011223-110F48FD-8BAA-4FB5-9733-FABCF2EF155DQ38203832-ACE1FE2F-2C6D-4C77-936F-67BF6D911C1BQ38728164-09035BDB-01EA-4373-96A9-3FA2328B29D7Q39401950-96F53A87-7981-4397-9E2C-2885C147FED0Q41852528-A5E95F96-0F22-4C27-B4A0-8F192289E94DQ57371978-FEED9C9E-0DBC-4C0B-A229-B468119706AFQ57379098-024BB4AB-37E3-4DC8-9E0A-6527AA9C0184
P2860
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@en
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@nl
type
label
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@en
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@nl
prefLabel
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@en
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@nl
P2093
P921
P1476
Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.
@en
P2093
Gary R Lichtenstein
Irene Sonu
Ming Valerie Lin
Wojciech Blonski
P304
P356
10.1016/J.GTC.2010.08.011
P577
2010-09-01T00:00:00Z